Residual Scope: 13-THY-03-AZ (D4203C00011) [VERIFY]Phase III Study of Vandetanib in Advanced Radioiodine Refractory Thyroid Cancers

Ain, Kenneth (PI)

Markey Cancer Center / Cancer Research Priority Initiative

Estado	Finalizado
Fecha de inicio/Fecha fin	7/1/17 → 11/29/21

13-THY-03-AZ (D4203C00011) [VERIFY]Phase III Study of Vandetanib in Advanced Radioiodine Refractory Thyroid Cancers
Ain, K. (PI)
7/1/17 → 11/29/21
Proyecto: Research project